News Quantified

FBRX – forte biosciences, inc. (US:NASDAQ)

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Forte Biosciences, Inc. (NASDAQ: FBRX) had its price target lowered by analysts at Chardan Capital from $64.00 to $61.00. They now have a "buy" rating on the stock.

Forte Biosciences, Inc. Announces Results and Provides Clinical Update

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Forte Biosciences, Inc. (NASDAQ: FBRX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.

Form 8-K Forte Biosciences, Inc. For: Mar 31

Form EFFECT Forte Biosciences, Inc.

Form 4 Forte Biosciences, Inc. For: Apr 01 Filed by: Riley Antony A

Form 4 Forte Biosciences, Inc. For: Apr 01 Filed by: Wagner Paul A.

Form S-3 Forte Biosciences, Inc.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}